328 web-development "https:" "https:" "https:" "Fraunhofer Gesellschaft" Postdoctoral positions at Nature Careers
Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
Project Description: Drug toxicity and resistance are the leading causes of therapeutic failures. The Chen Lab (https://www.stjude.org/research/labs/chen-lab-taosheng.html) studies: (1) the chemical
-
that ingest raw on-chain data (blocks, transactions, smart-contract events) from public blockchains into research-grade databases Developing statistical, graph, and/or machine learning models to study
-
The Microsystems and Nanotechnology Division at the National Institute of Standards and Technology (NIST), Gaithersburg, MD, is seeking postdoctoral researchers highly motivated to develop next
-
the development and application of advanced optical imaging and microscopy methods. The Hillman Lab brings together researchers from physics, engineering, and biology in a collaborative and intellectually open
-
human health. Within this mission, the Jug Group develops advanced computational methods and open scientific software to extract knowledge from complex biological imaging data. We work at the intersection
-
contribute to the development of a proof of concept obtained at University Côte d’Azur for accessing the content of a metabolomics knowledge graph (KG) with a large language model. It is Python prototype of a
-
Nordisk NERD grant, which will fund our research activities in quantum materials for the next 7 years. What we offer The successful candidate is offered: access to a well-developed research infrastructure
-
-generation AI models of gene regulation and disease progression. Our work is redefining Parkinson’s disease biology and enabling translational breakthroughs. The role Develop deep learning models across genome
-
in nanotechnology may also be considered. The Zhang laboratory functions as an integrated translational research program with the goal of designing and developing new immunotherapies and immunologic
-
inhouse developed long-acting GLP-1 receptor agonist, Efsubaglutide alfa , has achieved regulatory approval and market access in China representing a major milestone in biologics innovation originating from